Healthcare providers and payers can now benefit from AI medical imaging technology to screen for early signs of chronic disease in large populations.
enables more accurate risk-adjustment so patients are provided with preventative care paths they need, while improving quality of health services at significantly lower associated costs.
* Nanox AI solutions software based on medical imaging (CT or X-ray)
solutions were developed to target highly prevalent chronic and acute diseases affecting large populations everywhere. Healthcare systems and payers aim to reap the benefits of early detection and intervention to improve patient care, while reducing costs and risk. Sadly, it is not possible to screen everyone for everything all the time. Using medical imaging (CT or X-ray) already available to the system, Nanox AI’s solutions help physicians identify the early signs.
Identification of vertebral compression fractures (VCF from CT images), an early sign of osteoporosis, in an effort to help curb the disease’s long-term impact.
Analysis of non-gated CT images for Coronary Calcium Detection quantifies coronary artery calcium calcification, and early warning for asymptomatic patients suffering from coronary artery disease.
Facilitating risk-adjusted reimbursement through value-based payment programs such as Medicare Advantage.
A suite of radiological computer-aided triage and notification software indicated for use to aid with clinical assessment of Chest X-ray images for Pneumothorax (PNX) and Free Air (PPT), and non-contrast head CT images for Intracranial Hemorrhage (ICH).
Identification of vertebral compression fractures (VCF), an early sign of osteoporosis, in an effort to help curb the disease’s long-term impact.
Analysis of images for Coronary Calcium Detection (CCSng) quantifies coronary artery calcification, an early-warning for asymptomatic patients suffering from coronary artery disease.
Facilitating risk-adjusted reimbursement through value-based payment programs such as Medicare Advantage.
A suite of radiological computer-aided triage and notification software indicated for use in analysis, including Pneumothorax (PNX) and Free Air (PPT), and Intracranial Hemorrhage (ICH).
In a landmark approval, the American Medical Association (AMA) issued a new CPT named "Cat III-Assistive Augmented Intelligence Analysis," and defined as an "Accepted addition of code 0X36T to report an automated analysis of an existing computed tomography study for vertebral fractures."
This is a milestone towards smarter risk-adjustment of population healthcare plans—and potentially a game changer in the long term management of osteoporosis.
*Effective January 1, 2022.
The new code establishes a reimbursement pathway for use of Nanox.AI’s HealthCCSng, an FDA-cleared AI-enabled cardiac imaging solution that detects coronary artery calcium (CAC), for patients in the U.S, promoting broader adoption of AI for improved population health.
*Code will become effective July 1, 2022.
Nature Medicine volume 26, pages77–82(2020)
View publication
Journal of Digital Imaging, Volume 30, Issue 4
- Join a growing, dynamic company that offers great opportunities to its employees.
